Metabolic Dysfunction‐Associated Steatotic Liver Disease Is Associated With Accelerated Brain Ageing: A Population‐Based Study
Liver International · 2025-06 · 45 (6)
DOI: 10.1111/liv.70109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, online erschienen am 29.04.2025. Verfasst von Jiao Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center of Gerontology and Geriatrics, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Brain, Aging, Fatty Liver. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Karolinska Institutet Research Grants, Lindhés Advokatbyrå AB, Science Technology Development Fund of Tianjin Education Commission for Higher Education.
Abstract (Originalsprache)
Background
Metabolic dysfunction‐associated steatotic liver disease (MASLD) is linked to cognitive decline and dementia risk. We aimed to investigate the association between MASLD and brain ageing and explore the role of low‐grade inflammation.
Methods
Within the UK Biobank, 30 386 chronic neurological disorders‐free participants who underwent brain magnetic resonance imaging (MRI) scans were included. Individuals were categorised into no MASLD/related SLD and MASLD/related SLD (including subtypes of MASLD, MASLD with increased alcohol intake [MetALD] and MASLD with other combined aetiology). Brain age was estimated using machine learning by 1079 brain MRI phenotypes. Brain age gap (BAG) was calculated as the difference between brain age and chronological age. Low‐grade inflammation (INFLA) was calculated based on white blood cell count, platelet, neutrophil granulocyte to lymphocyte ratio and C‐reactive protein. Data were analysed using linear regression and structural equation models.
Results
At baseline, 7360 (24.2%) participants had MASLD/related SLD. Compared to participants with no MASLD/related SLD, those with MASLD/related SLD had significantly larger BAG ( β = 0.86, 95% CI = 0.70, 1.02), as well as those with MASLD ( β = 0.59, 95% CI = 0.41, 0.77) or MetALD ( β = 1.57, 95% CI = 1.31, 1.83). The association between MASLD/related SLD and larger BAG was significant across middle‐aged (< 60) and older (≥ 60) adults, males and females, and APOE ɛ4 carriers and non‐carriers. INFLA mediated 13.53% of the association between MASLD/related SLD and larger BAG ( p < 0.001).
Conclusion
MASLD/related SLD, as well as MASLD and MetALD, is associated with accelerated brain ageing, even among middle‐aged adults and APOE ɛ4 non‐carriers. Low‐grade systemic inflammation may partially mediate this association.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center of Gerontology and Geriatrics, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
- Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
- Public Health Science and Engineering College, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
- Tianjin Key Laboratory of Elderly Health, Department of Geriatrics, Tianjin Geriatrics Institute, Tianjin Medical University General Hospital, Tianjin, China.
- Department of Pediatric Neurosurgery, West China Second University Hospital, Sichuan University, Chengdu, China.
- Department of Health Sciences, The Swedish Red Cross University, Huddinge, Sweden.
ORCID-Profile: Jiao Wang, Stéphanie Paillard-Borg, Weili Xu
Förderung
- Karolinska Institutet Research Grants
- Lindhés Advokatbyrå AB
- Science Technology Development Fund of Tianjin Education Commission for Higher Education
- Fort Foundation
- Vetenskapsrådet
- Forskningsrådet för arbetsliv, hälsa och välfärd
- Natural Science Foundation of Chongqing Municipality
- National Natural Science Foundation of China
Zitieren
APA
Wang, J., Yang, R., Miao, Y., Zhang, X., Paillard-Borg, S., Fang, Z., & Xu, W. (2025). Metabolic Dysfunction‐Associated Steatotic Liver Disease Is Associated With Accelerated Brain Ageing: A Population‐Based Study. Liver International, 45(6). https://doi.org/10.1111/liv.70109
Vancouver
Wang J, Yang R, Miao Y, Zhang X, Paillard-Borg S, Fang Z, et al. Metabolic Dysfunction‐Associated Steatotic Liver Disease Is Associated With Accelerated Brain Ageing: A Population‐Based Study. Liver International. 2025;45(6). doi:10.1111/liv.70109
BibTeX
@article{Wang2025,
author = {Wang, Jiao and Yang, Rongrong and Miao, Yuyang and Zhang, Xinjie and Paillard-Borg, Stéphanie and Fang, Zhongze and Xu, Weili},
title = {Metabolic Dysfunction‐Associated Steatotic Liver Disease Is Associated With Accelerated Brain Ageing: A Population‐Based Study},
journal = {Liver International},
year = {2025},
volume = {45},
number = {6},
doi = {10.1111/liv.70109}
}
EUVIMED